Delivery Order SPE2DB20D3103-SPE2DB23FM5V3
- Not listed
- This federal contract award is for the delivery of Clarithromycin 500 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,083.46, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,272,269 tablets of Clarithromycin 500 mg to the U.S. Department of Defense (DoD). The contract, a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $1,035.37 and a completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,440 Clarithromycin 500 mg tablets. The contract is a Delivery Order valued at $2,050.60 with a firm fixed price and an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp's Corporate Office Division holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,451.36 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,639,679 units of Clarithromycin 500 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical division, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,266.28 firm fixed-price delivery order is for the supply of 4,566,658,239 units of Clarithromycin 500 mg tablets. The contract has an ultimate completion date of December 10, 2024 and was awarded on December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of clarithromycin 500 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract has a firm fixed price and a potential value of $1,413.58, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $5,223.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,456,466 Clarithromycin 500 mg tablets. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment programs and facilities worldwide....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of clarithromycin 500 mg tablets. The contract, valued at $4,388.49, was awarded on May 8, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation mentioned for this award. Amerisourcebergen, one of the largest pharmaceutical...
- This contract award is for the delivery of Clarithromycin 500 mg tablets to the Defense Logistics Agency (DLA). The $3,167.68 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 11, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This single-award IDC, which...
- This federal contract award is for the delivery of Clarithromycin 250 mg tablets in 60-count packages, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $1,769.02 and a completion date of February 15, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that provides a wide range of pharmaceutical products and...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM5V3Delivery Order
This federal contract award is for the delivery of 4,560,070,715 tablets of Clarithromycin 500 mg to the Defense Logistics Agency (DLA). The contract, valued at $1,157.91, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 27, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 28, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/27/23 |